Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.

作者信息

Tfelt-Hansen Peer C, Diener Hans-Christoph

机构信息

Danish Headache Center, Department of Neurology, Glostrup Hospital, Glostrup, Denmark.

出版信息

Headache. 2014 Oct;54(9):1523-5. doi: 10.1111/head.12389. Epub 2014 May 26.

DOI:10.1111/head.12389

PMID:24862945

Abstract

摘要

相似文献

Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.

Headache. 2014 Oct;54(9):1523-5. doi: 10.1111/head.12389. Epub 2014 May 26.

Ergotamine, dihydroergotamine: current uses and problems.

Curr Med Res Opin. 2001;17 Suppl 1:s30-4. doi: 10.1185/0300799039117009.

Patient information regarding subcutaneous self-administration of dihydroergotamine (DHE).

Headache. 2007 May;47(5):740. doi: 10.1111/j.1526-4610.2007.00803.x.

Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.

Ann Emerg Med. 1998 Aug;32(2):129-38. doi: 10.1016/s0196-0644(98)70126-x.

[Transformed migraine--chronic daily headache].

Tidsskr Nor Laegeforen. 1999 Nov 30;119(29):4311-3.

[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].

Pathol Biol (Paris). 1995 Nov;43(9):806-13.

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.

Curr Pain Headache Rep. 2005 Feb;9(1):65-70. doi: 10.1007/s11916-005-0077-5.

MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.

Headache. 2011 Apr;51(4):507-17. doi: 10.1111/j.1526-4610.2011.01869.x.

Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.

Headache. 1997;37 Suppl 1:S33-41.

Intravenous dihydroergotamine for inpatient management of refractory primary headaches.

Neurology. 2011 Nov 15;77(20):1827-32. doi: 10.1212/WNL.0b013e3182377dbb. Epub 2011 Nov 2.

引用本文的文献

Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial.

J Headache Pain. 2025 Jan 2;26(1):1. doi: 10.1186/s10194-024-01915-y.

Treatment of headache following triptan failure after successful triptan therapy.

Curr Treat Options Neurol. 2015 Jun;17(6):353. doi: 10.1007/s11940-015-0353-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验